XRF Scientific Resultados de beneficios anteriores

Pasado controles de criterios 3/6

XRF Scientific ha aumentado sus beneficios a una tasa media anual de 29.1%, mientras que los beneficios de la industria de Machinery han experimentado un crecimiento de 30.2% anual. Los ingresos han ido creciendo a una tasa media de 16.7% al año. La rentabilidad financiera de XRF Scientific es de 17.4%, y sus márgenes netos son de 14.8%.

Información clave

29.1%

Tasa de crecimiento de los beneficios

28.5%

Tasa de crecimiento del BPA

Crecimiento de la industria Machinery	29.3%
Tasa de crecimiento de los ingresos	16.7%
Rentabilidad financiera	17.4%
Margen neto	14.8%
Última actualización de beneficios	31 Dec 2023

Actualizaciones de resultados anteriores recientes

Recent updates

Is Now The Time To Look At Buying XRF Scientific Limited (ASX:XRF)?

Feb 12

Returns On Capital Are A Standout For XRF Scientific (ASX:XRF)

Jan 18

Why The 22% Return On Capital At XRF Scientific (ASX:XRF) Should Have Your Attention

Oct 05

An Intrinsic Calculation For XRF Scientific Limited (ASX:XRF) Suggests It's 23% Undervalued

Mar 17

XRF Scientific (ASX:XRF) Strong Profits May Be Masking Some Underlying Issues

Mar 01

Is Now The Time To Put XRF Scientific (ASX:XRF) On Your Watchlist?

Feb 17

Our View On XRF Scientific's (ASX:XRF) CEO Pay

Jan 27

Who Has Been Selling XRF Scientific Limited (ASX:XRF) Shares?

Jan 12

XRF Scientific Limited's (ASX:XRF) Fundamentals Look Pretty Strong: Could The Market Be Wrong About The Stock?

Dec 23

XRF Scientific Limited's (ASX:XRF) Intrinsic Value Is Potentially 22% Below Its Share Price

Dec 10

The Returns At XRF Scientific (ASX:XRF) Provide Us With Signs Of What's To Come

Nov 25

Desglose de ingresos y gastos
Beta

Cómo gana y gasta dinero XRF Scientific. Basado en los últimos beneficios reportados, en base a los últimos doce meses (LTM).

Historial de beneficios e ingresos

ASX:XRF Ingresos, gastos y beneficios (AUD Millions)
Fecha	Ingresos	Beneficios	Gastos G+A
31 Dec 23	57	8	10
30 Sep 23	56	8	10
30 Jun 23	55	8	10
31 Mar 23	52	7	10
31 Dec 22	49	7	10
30 Sep 22	44	7	9
30 Jun 22	40	6	9
31 Mar 22	37	6	8
31 Dec 21	35	6	8
30 Sep 21	33	5	8
30 Jun 21	31	5	7
31 Mar 21	30	5	7
31 Dec 20	28	4	7
30 Sep 20	29	3	7
30 Jun 20	29	3	7
31 Mar 20	29	3	7
31 Dec 19	30	3	7
30 Sep 19	29	2	7
30 Jun 19	29	2	7
31 Mar 19	28	2	7
31 Dec 18	27	2	7
30 Sep 18	26	1	7
30 Jun 18	24	1	7
31 Mar 18	24	1	7
31 Dec 17	23	1	7
30 Sep 17	22	1	7
30 Jun 17	22	1	7
31 Mar 17	22	1	7
31 Dec 16	22	1	6
30 Sep 16	21	1	6
30 Jun 16	21	2	6
31 Mar 16	20	2	5
31 Dec 15	20	2	5
30 Sep 15	20	2	5
30 Jun 15	21	3	5
31 Mar 15	21	3	5
31 Dec 14	22	3	5
30 Sep 14	22	3	4
30 Jun 14	22	2	4
31 Mar 14	21	3	4
31 Dec 13	20	3	4
30 Sep 13	21	3	4
30 Jun 13	23	4	4

Ingresos de calidad: XRF tiene ganancias de alta calidad.

Margen de beneficios creciente: Los actuales márgenes de beneficio (14.8%) de XRF son superiores a los del año pasado (14.5%).

Análisis del flujo de caja libre vs. Beneficios

Análisis del crecimiento de los beneficios en el pasado

Tendencia de beneficios: En los últimos 5 años, los beneficios de lXRF han crecido significativamente en un 29.1% al año.

Acelerando crecimiento: El crecimiento de los beneficios de XRF en el último año (19.9%) está por debajo de su media de 5 años (29.1% al año).

Beneficios vs. Industria: El crecimiento de los beneficios de XRF en el último año (19.9%) no superó al de la industria Machinery 41%.

XRF Scientific Resultados de beneficios anteriores

Pasado controles de criterios 3/6

Información clave

Actualizaciones de resultados anteriores recientes

First half 2024 earnings released: EPS: AU$0.033 (vs AU$0.028 in 1H 2023)

Full year 2023 earnings: EPS and revenues miss analyst expectations

First half 2023 earnings released: EPS: AU$0.028 (vs AU$0.021 in 1H 2022)

Full year 2022 earnings released: EPS: AU$0.045 (vs AU$0.038 in FY 2021)

First half 2022 earnings: EPS exceeds analyst expectations while revenues lag behind

Full year 2021 earnings released: EPS AU$0.038 (vs AU$0.023 in FY 2020)

Recent updates

First half 2024 earnings released: EPS: AU$0.033 (vs AU$0.028 in 1H 2023)

Is Now The Time To Look At Buying XRF Scientific Limited (ASX:XRF)?

Returns On Capital Are A Standout For XRF Scientific (ASX:XRF)

New minor risk - Market cap size

Investor sentiment improves as stock rises 15%

Now 22% undervalued after recent price drop

Why The 22% Return On Capital At XRF Scientific (ASX:XRF) Should Have Your Attention

XRF Scientific Limited, Annual General Meeting, Oct 31, 2023

Upcoming dividend of AU$0.033 per share at 3.0% yield

XRF Scientific (ASX:XRF) Is Increasing Its Dividend To A$0.033

XRF Scientific's (ASX:XRF) Upcoming Dividend Will Be Larger Than Last Year's

New minor risk - Dividend sustainability

Full year 2023 earnings: EPS and revenues miss analyst expectations

Do XRF Scientific's (ASX:XRF) Earnings Warrant Your Attention?

XRF Scientific Limited Announces Ordinary Fully Paid Dividend for the Twelve Months Ended June 30, 2023, Payment Date of October 13, 2023

Non-Executive Director recently bought AU$89k worth of stock

New minor risk - Market cap size

Investor sentiment improves as stock rises 19%

Non-Executive Director recently bought AU$61k worth of stock

Investor sentiment improves as stock rises 18%

Now 23% undervalued

First half 2023 earnings released: EPS: AU$0.028 (vs AU$0.021 in 1H 2022)

Does XRF Scientific (ASX:XRF) Deserve A Spot On Your Watchlist?

Insufficient new directors

Now 21% undervalued

XRF Scientific (ASX:XRF) Seems To Use Debt Rather Sparingly

XRF Scientific Limited Announces Dividend That Relates to the Financial Reporting or Payment Period Ended on June 30, 2022, Payable on October 14, 2022

Upcoming dividend of AU$0.025 per share

XRF Scientific Limited, Annual General Meeting, Oct 21, 2022

Full year 2022 earnings released: EPS: AU$0.045 (vs AU$0.038 in FY 2021)

XRF Scientific Limited Announces Fully Franked Ordinary Dividend for the Year Ended June 30, 2022, Payable on 14 October 2022

Now 20% undervalued

We Think XRF Scientific (ASX:XRF) Can Manage Its Debt With Ease

Now 24% undervalued

Price target increased to AU$0.65

Insufficient new directors

XRF Scientific (ASX:XRF) Shareholders Will Want The ROCE Trajectory To Continue

First half 2022 earnings: EPS exceeds analyst expectations while revenues lag behind

Insufficient new directors

Is Now The Time To Put XRF Scientific (ASX:XRF) On Your Watchlist?

Upcoming dividend of AU$0.02 per share

Full year 2021 earnings released: EPS AU$0.038 (vs AU$0.023 in FY 2020)

Price target increased to AU$0.46

Non-Executive Director recently bought AU$72k worth of stock

XRF Scientific (ASX:XRF) Is Looking To Continue Growing Its Returns On Capital

Does XRF Scientific (ASX:XRF) Have A Healthy Balance Sheet?

An Intrinsic Calculation For XRF Scientific Limited (ASX:XRF) Suggests It's 23% Undervalued

XRF Scientific (ASX:XRF) Strong Profits May Be Masking Some Underlying Issues

Non-Executive Director recently bought AU$93k worth of stock

New 90-day low: AU$0.28

First half 2021 earnings released: EPS AU$0.018 (vs AU$0.012 in 1H 2020)

Earnings beat expectations, revenue disappoints

Is Now The Time To Put XRF Scientific (ASX:XRF) On Your Watchlist?

Our View On XRF Scientific's (ASX:XRF) CEO Pay

Who Has Been Selling XRF Scientific Limited (ASX:XRF) Shares?

XRF Scientific Limited's (ASX:XRF) Fundamentals Look Pretty Strong: Could The Market Be Wrong About The Stock?

XRF Scientific Limited's (ASX:XRF) Intrinsic Value Is Potentially 22% Below Its Share Price

The Returns At XRF Scientific (ASX:XRF) Provide Us With Signs Of What's To Come

New 90-day low: AU$0.28

New 90-day high: AU$0.34

Earnings released

New 90-day high - AU$0.30

New 90-day high - AU$0.29

Desglose de ingresos y gastosBeta

Historial de beneficios e ingresos

Análisis del flujo de caja libre vs. Beneficios

Análisis del crecimiento de los beneficios en el pasado

Rentabilidad financiera

Rentabilidad económica

Desglose de ingresos y gastos
Beta